Clinical Trials in San Francisco

Showing 3241-3260 of 12,991 trials

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

NCT05924477

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris and front chamber of the eye) in efforts to minimize cell loss in the eye.

Glaucoma

University of Pennsylvania226 participantsStarted Jul 2023

San Francisco, California, United States • Walnut Creek, California, United States • Miami, Florida, United States +5 more locations

TERMINATEDPhase 2< 1 mile

A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

NCT03248492

Some human epidermal growth factor receptor 2 (HER-2) breast cancer patients do not respond or become resistant to current treatment. DS-8201a is a new experimental product that is a combination of an antibody and a drug. It has not yet been approved for use. DS-8201a may slow down tumor growth. This might improve outcomes for these patients.

Breast Cancer

Daiichi Sankyo253 participantsStarted Aug 2017

Anchorage, Alaska, United States • Tucson, Arizona, United States • Los Angeles, California, United States +96 more locations

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

Find Trials by Condition in San Francisco

COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

Biology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment

Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa

Comparison of Two Nutrition-Based Interventions on Physician Well-being

Post-Approval Study of the TREO Abdominal Stent-Graft System

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

Cough Reduction in IPF With Nalbuphine ER

Implementing Precision Medicine in cOmmunity HospiTALs